Skip to main content

Geron Corp

GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000886744

No open-market purchases or sales by Geron Corp insiders were filed in the last 90 days; 260 institutions reported holding it in 13F filings for Q2 2026, worth $610.5M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Geron Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of GERN: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders1452139−4
Shares130.0M49.0K131.9M+1.94M (+1.5%)
Value$181.6M$69.0K$179.0M−$2.57M (−1.4%)

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Geron Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to GERN in Q3 2021
InstitutionSharesValue% of portfolio
MPM Oncology Impact Management LP5,732,770$7.85M1.22%
Pictet Asset Management SA37,400$51.0K0.00%
Jump Financial, LLC26,600$36.0K0.00%
Janus Henderson Group PLC24,284$33.0K0.00%
E Fund Management Co., Ltd.21,560$30.0K0.00%
Dynamic Technology Lab Private Ltd17,282$24.0K0.00%
Ameriprise Financial Inc12,560$17.0K0.00%
Cetera Advisors LLC12,230$17.0K0.00%
Two Sigma Securities, LLC11,315$16.0K0.00%
PSI Advisors, LLC5,000$7.00K0.00%
Community Bank, N.A.300$00.00%
Bell Investment Advisors, Inc299$00.00%

Sold out (16)

Institutions that held Geron Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (2)

Institutions that held Geron Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GERN in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Pictet Asset Management Ltd37,400$53.0K
Elmwood Wealth Management, Inc.11,650$16.0K